SI2588101T1 - Derivati N-acil amino kisline za zdravljenje koĹľnih stanj, kot je celulitis - Google Patents

Derivati N-acil amino kisline za zdravljenje koĹľnih stanj, kot je celulitis

Info

Publication number
SI2588101T1
SI2588101T1 SI201130336T SI201130336T SI2588101T1 SI 2588101 T1 SI2588101 T1 SI 2588101T1 SI 201130336 T SI201130336 T SI 201130336T SI 201130336 T SI201130336 T SI 201130336T SI 2588101 T1 SI2588101 T1 SI 2588101T1
Authority
SI
Slovenia
Prior art keywords
cellulite
amino acid
acid derivatives
skin conditions
acyl amino
Prior art date
Application number
SI201130336T
Other languages
English (en)
Inventor
Timothy J. Falla
Lijuan Zhang
Original Assignee
Helix Biomedix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix, Inc. filed Critical Helix Biomedix, Inc.
Publication of SI2588101T1 publication Critical patent/SI2588101T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI201130336T 2010-07-02 2011-06-28 Derivati N-acil amino kisline za zdravljenje koĹľnih stanj, kot je celulitis SI2588101T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36117910P 2010-07-02 2010-07-02
EP11731209.0A EP2588101B1 (en) 2010-07-02 2011-06-28 N-acyl amino acid derivatives for treating skin conditions such as cellulite
PCT/US2011/042123 WO2012003176A1 (en) 2010-07-02 2011-06-28 N-acyl amino acid derivatives for treating skin conditions such as cellulite

Publications (1)

Publication Number Publication Date
SI2588101T1 true SI2588101T1 (sl) 2015-01-30

Family

ID=44326260

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130336T SI2588101T1 (sl) 2010-07-02 2011-06-28 Derivati N-acil amino kisline za zdravljenje koĹľnih stanj, kot je celulitis

Country Status (22)

Country Link
US (1) US9511042B2 (sl)
EP (1) EP2588101B1 (sl)
JP (1) JP6043283B2 (sl)
KR (1) KR101639196B1 (sl)
CN (1) CN103079553B (sl)
AR (1) AR082277A1 (sl)
AU (1) AU2011271466B2 (sl)
BR (1) BR112013000045A2 (sl)
CA (1) CA2800301C (sl)
DK (1) DK2588101T3 (sl)
ES (1) ES2528012T3 (sl)
HK (1) HK1179893A1 (sl)
MX (1) MX362721B (sl)
MY (1) MY156618A (sl)
NZ (1) NZ605804A (sl)
PL (1) PL2588101T3 (sl)
RU (1) RU2590977C2 (sl)
SG (1) SG186234A1 (sl)
SI (1) SI2588101T1 (sl)
TW (1) TWI539945B (sl)
WO (1) WO2012003176A1 (sl)
ZA (1) ZA201209603B (sl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6473505B2 (ja) * 2014-08-28 2019-02-20 カリウェイ バイオファーマシューティカルズ カンパニー リミテッド 局所の脂肪と体重の減少に用いられる組成物およびその医薬品と使用
US10226503B2 (en) 2014-08-28 2019-03-12 Caliway Biopharmaceuticals Co., Ltd. Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof
MX2018002462A (es) 2015-08-28 2018-06-19 Caliway Biopharmaceuticals Co Ltd Una composicion farmaceutica para reducir la grasa localizada y sus usos.
US11318110B2 (en) 2015-08-28 2022-05-03 Caliway Biopharmaceuticals Co., Ltd. Pharmaceutical composition for reducing local fat and uses thereof
BR112018077141B1 (pt) * 2016-07-27 2022-02-01 Unilever Ip Holdings B.V. Composição de cuidados pessoais e usos de uma composição de cuidados da pele
WO2019071093A1 (en) * 2017-10-05 2019-04-11 North Carolina State University ALKAMIDE COMPOUNDS AND USES THEREOF

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85643A1 (fr) 1984-11-16 1986-06-04 Oreal Composition cosmetique thermo-amincissante a base d'extraits vegetaux oleosolubles
US5510531A (en) 1989-04-10 1996-04-23 Suntory Limited Proteinase inhibitor
JP2701932B2 (ja) * 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
DK255889D0 (da) 1989-05-25 1989-05-25 Novo Nordisk As Fremgangsmaade til fremstilling af organiske forbindelser
EP0500332B1 (en) * 1991-02-19 1998-05-27 National Food Research Institute Ministry Of Agriculture, Forestry And Fisheries Novel acylamino acid compounds and a method for their production
JPH08337515A (ja) * 1995-04-11 1996-12-24 Kashima Sekiyu Kk 化粧料
FR2789085B1 (fr) * 1999-01-29 2003-06-20 Arkopharma Laboratoires Procede d'obtention d'une huile enrichie en acides gras hydroxyoctadecadienoiques (hode), ou de ses esters a partir d'un melange huileux contenant de l'acide linoleique, ou ses esters
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
CN1523982A (zh) 2001-03-27 2004-08-25 ���������Ǵ�ѧ���»� 减少体脂和调节脂肪酸代谢的方法、化合物和组合物
US20050019372A1 (en) 2001-07-10 2005-01-27 Barbara E Corkey Modified-fat nutritional products useful preventing or treating obesity
ITMI20030210A1 (it) * 2003-02-07 2004-08-08 Res & Innovation Soc Coop A R L Composti endocannabinoido-simili e loro impiego
JP2005194252A (ja) * 2004-01-09 2005-07-21 Shiseido Co Ltd 脂肪蓄積抑制用組成物
WO2006029818A2 (en) 2004-09-16 2006-03-23 Dsm Ip Assets B.V. Cosmetic compositions containing an hydroxamic acid compound optionally in combination with a retinoid
JP4527655B2 (ja) * 2004-11-30 2010-08-18 ライオン株式会社 フォーマー容器入り洗浄剤組成物
JP2008105945A (ja) 2005-02-07 2008-05-08 Ajinomoto Co Inc アディポネクチンの分泌促進又は誘導作用を有するアシルアミド化合物
JP2007153845A (ja) * 2005-12-07 2007-06-21 Yamaha Motor Co Ltd 脂肪蓄積抑制剤
JP5105297B2 (ja) * 2006-05-25 2012-12-26 味の素株式会社 Ｐｐａｒ活性調節剤
DE102006060439A1 (de) * 2006-12-19 2008-06-26 Henkel Kgaa Verbesserung der Hautverträglichkeit von hyperämisierenden Wirkstoffen
US20080200704A1 (en) 2007-02-20 2008-08-21 Multi Formulations Ltd. Preparation of amino acid-fatty acid amides

Also Published As

Publication number Publication date
TWI539945B (zh) 2016-07-01
RU2590977C2 (ru) 2016-07-10
MX2012014751A (es) 2013-02-15
CA2800301C (en) 2018-03-27
AU2011271466B2 (en) 2013-08-22
DK2588101T3 (en) 2015-02-02
MY156618A (en) 2016-03-15
CA2800301A1 (en) 2012-01-05
TW201201794A (en) 2012-01-16
KR101639196B1 (ko) 2016-07-14
US20130096143A1 (en) 2013-04-18
JP6043283B2 (ja) 2016-12-14
SG186234A1 (en) 2013-01-30
ES2528012T3 (es) 2015-02-03
AR082277A1 (es) 2012-11-28
BR112013000045A2 (pt) 2016-05-10
PL2588101T3 (pl) 2015-03-31
RU2013104424A (ru) 2014-08-10
JP2013530233A (ja) 2013-07-25
KR20130029432A (ko) 2013-03-22
HK1179893A1 (en) 2013-10-11
EP2588101A1 (en) 2013-05-08
EP2588101B1 (en) 2014-10-22
WO2012003176A1 (en) 2012-01-05
AU2011271466A1 (en) 2012-12-20
MX362721B (es) 2015-02-27
US9511042B2 (en) 2016-12-06
CN103079553B (zh) 2016-01-20
ZA201209603B (en) 2013-08-28
NZ605804A (en) 2014-03-28
CN103079553A (zh) 2013-05-01

Similar Documents

Publication Publication Date Title
IL262611A (en) Treatment for lipodystrophy
HK1221917A1 (zh) 用於治療退化骨病症的方法
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
ZA201209484B (en) Skin antiaging treatment
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
ZA201208413B (en) Skin treatment composition
HK1178465A1 (en) Composition for improving condition of skin
EP2544655A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN
EP2621498A4 (en) COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
HK1179893A1 (en) N-acyl amino acid derivatives for treating skin conditions such as cellulite n-
GB0902040D0 (en) Composition for treatment of skin
ZA201303222B (en) Composition and method for treating skin conditions
IL224381B (en) Application of b-functionalized dihydroxy-chlorins for pdt
PL392436A1 (pl) Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
IL225755A0 (en) Amido-6 derivatives of epoxymorphinans-a5, 4 for the treatment of pain
ZA201208568B (en) Skin treatment composition
EP2616485A4 (en) STEPPED DEVELOPED PEPTIDE FOR THE TREATMENT OF BRAIN INJURIES
EP2454229A4 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
HK1214771A1 (zh) 用於治療皮膚病的製劑
GB201010638D0 (en) Composition for treatment of skin
PT2456445E (pt) Agente para o tratamento de condições da pele
ZA201005770B (en) The treatment of damaged skin
GB201016836D0 (en) Composition for skin treatment
GB201016834D0 (en) Composition for skin treatment
GB201014212D0 (en) Apparatus for in-vivo skin characterisation